Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib in Desmoid Tumor and Chondrosarcoma
NCT00928525Phase 2Completed
- Sponsor
- Italian Sarcoma Group
- Start
- May 2007
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in desmoid tumor, chondrosarcoma, sponsored by Italian Sarcoma Group. Started May 2007; status: completed.
02
Drugs
03
Conditions
desmoid tumorchondrosarcoma
Beyond the preview
Go deeper on NCT00928525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00928525.